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1 These authors contributed equally.Cdc25 phosphatases activate Cdk/Cyclin complexes by dephosphorylation and thus promote cell
cycle progression. We observed that the peak activity of Cdc25A precedes the one of Cdc25B in pro-
phase and the maximum of Cyclin/Cdk kinase activity. Furthermore, Cdc25A activates both Cdk1–2/
Cyclin A and Cdk1/Cyclin B complexes while Cdc25B seems to be involved only in activation of Cdk1/
Cyclin B. Concomitantly, repression of Cdc25A led to a decrease in Cyclin A-associated kinase activ-
ity and attenuated Cdk1 activation. Our results indicate that Cdc25A acts before Cdc25B – at least in
cancer cells, and has non-redundant functions in late G2/early M-phase as a major regulator of
Cyclin A/kinase complexes.
 2009 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
In mammalian cells, the Cdc25 phosphatase family consists of
three isoforms named Cdc25A, B and C [1]. Cdc25B has an exclu-
sive role in centrosome separation in late G2 [2], and presumably
acts as a trigger of mitotic onset [3–5]. Mice lacking both Cdc25B
and Cdc25C develop normally indicating that these phosphatases
are not required for mouse embryogenesis and cell cycle progres-
sion in somatic cells, whereas loss of Cdc25A causes an early
embryonic lethality [6]. Functions of Cdc25A at the G1–S
transition or in DNA damage response are well described [7–
10], whereas its role in mitosis remains unclear. Transient
repression of Cdc25A or Cdc25B by siRNA delays the G2–M tran-
sition [2] while their overexpression induce premature Cdk1 acti-
vation and entry into mitosis [7,11]. An existing model places
Cdc25A immediately downstream of Cdc25B which acts along
with Cdc25B and Cdc25C to provide a maximal level of Cdk1 ki-
nase activity in metaphase [11]. This model, however, does not
explain why inhibition of Cdc25A dramatically affects M-phase
progression despite the presence of fully active Cdc25B and
Cdc25C.on behalf of the Federation of Euro
ann).2. Materials and methods
2.1. Cell culture conditions
U2OS cells were cultured in Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM) supplemented with 10% heat inactivated fetal calf
serum (Gibco), 2 lg/ml tetracycline, penicillin (100 U/ml) and
streptomycin (100 lg/ml) in a humidiﬁed atmosphere containing
5% CO2 at 37 C.2.2. Immunoblotting and immunoprecipitations
Preparation of cell extracts, immunoprecipitations and immu-
noblotting were performed as described previously [8]. The follow-
ing antibodies were used in Western Blots: Cdc25A (M-191)
Cdc25B (C-20), Cyclin A (H-432), Cdk1 (p34) (all from Santa Cruz
Biotechnology, Heidelberg, Germany); Cyclin B [12], pSer10-H3
(Upstate Biotechnology, Schwalbach, Germany), Cdk2 [13], a-tubu-
lin, b-actin, c-tubulin (Sigma, Munich, Germany).
2.3. Kinase and phosphatase assays
Cdc25 phosphatase activity was measured indirectly as the abil-
ity to activate Cyclin B/Cdk1 complexes immunoprecipitated from
S-phase arrested cells or puriﬁed recombinant Cyclin B/Cdk1 phos-
phorylated by Myt1. For immunoprecipitation of Cdc25,pean Biochemical Societies.
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B complexes were immunoprecipitated using anti-Cyclin B anti-
bodies [12]. Phosphatase and kinase assays were performed as de-
scribed previously [12].
2.4. siRNA experiments
Short hairpin RNAs (shRNAs) were cloned into the pSu-
per.GFP.neo vector (Oligoengine Inc., Seattle, WA). Full sequences
of oligonucleotides used, corresponding to positions 84–102 andFig. 1. Cdc25A phosphatase activity peaks before Cdc25B. (A) Left panel: HeLa cells were s
medium for 10 h, followed by thymidine re-addition for 17 h. Lysates from indicated time
Cdc25B; b-actin antibodies served as a loading control. One of four representative experim
panel: HeLa cells expressing GFP-histone H2B were synchronized and released as in (A)
FACS analysis. (C) Lysates from (B) were used in IP and subsequent phosphatase assays423–441 of human Cdc25A ORF and positions 287–305 and 698–
716 of human Cdc25B ORF are available upon request. shRNA tar-
getting ﬁreﬂy luciferase was used as a control.
3. Results and discussion
To gain more insight into the functions of Cdc25A at the onset of
mitosis we ﬁrst compared Cdc25A and Cdc25B protein levels in a
time-course of HeLa cells synchronized by a double thymidine
block and release. Both proteins start to increase at 3 h. Cdc25Aynchronized by a double thymidine block, cells were washed and released into fresh
-points were resolved on SDS–PAGE and probed with antibodies against Cdc25A and
ents is shown. Right panel: FACS analysis data from samples taken in (A). (B) Upper
and recorded using video microscopy. Lower panel: some of the cells were ﬁxed for
. Error bars represent standard deviations in three independent experiments.
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whereas levels of Cdc25B increased up to eight hours and then re-
mained constant (Fig. 1A). FACS analysis of cells showed that the
majority of cells were in G2 or M-phases as early as 8 h after re-
lease from the block (Fig. 1A). Similar results were obtained when
cells were synchronized using nocodazole block and release (not
shown). To test whether activation of Cdc25A and Cdc25B changes
along with their protein levels, HeLa cells stably expressing GFP-
tagged histone H2B were used to monitor cell cycle progression
visually. After releasing cells from a double thymidine block we fo-
cused on chromatin morphology to collect samples, in which the
main population of cells represented G2 and prophase, prophase
and prometaphase or metaphase and anaphase cells, respectively
(Fig. 1B). We used these samples for Cdc25 phosphatase assays.
The peak of Cdc25A activity was observed in prophase coinciding
with the maximum of its protein levels whereas Cdc25B activity
rose later in metaphase (Fig. 1C). Taken together, our data suggest
that although Cdc25A and B protein levels arise at about the sameFig. 2. Cdc25A is stabilized and accumulated in early mitosis. (A) U2OS cells were ﬁxed w
anti-pSer10 histone H3 antibodies. In three independent experiments 50 cells in each s
measured at certain stages of mitosis was considered as 1 (for cdc25A – prometaphase,
each cell by dividing by the highest average intensity. (B) Left panel: U2OS cells were ﬁxed
anti-Cyclin A or anti-Cyclin B antibodies, DNA stained with DAPI. Representative inter
experiments were analyzed. Right panel: relative signal intensities calculated as describe
thymidine block and harvested at different intervals after release upon treatment with
against Cdc25A, Cdc25B or a-tubulin. One representative experiment out of three is sho
time-points, corresponding to the WB.time after S-phase block and release Cdc25A activation clearly pre-
cedes the one of Cdc25B at entry into mitosis.
To explore the timing of Cdc25A accumulation more precisely
we examined synchronized U2OS or HeLa cells at different time-
points after release from the double thymidine block. To identify
cells in G2 phase and discern stages of mitosis we used anti-phos-
pho histone H3 antibodies in combination with Cdc25A staining
and monitored DNA content by staining with Hoechst. First signs
of pH3 Ser10 phosphorylation appear in early prophase, when the
nuclear envelope is still intact, but centrosomes are already sepa-
rated, although not yet at their polar positions. At the same time
relocation of Cyclin B to the nucleus begins. In agreement with
the results of western blotting, Cdc25A protein levels progressively
increased from early/mid-G2 and reached their maximum in pro-
metaphase (Fig. 2A). It is known that Cdc25A shuttles between nu-
cleus and cytoplasm throughout the cell cycle, and that its nuclear
import surpasses the export [14]. Therefore, in interphase Cdc25A is
more abundant in the nucleus. We observed that in late G2 a part ofith PFA and permeablized with Triton X-100. Cells were exposed to anti-Cdc25A and
tage of the cell cycle were analyzed. The highest average intensity of signals in cells
for pSer10-H3 – metaphase), and the relative signal intensities were calculated for
and stained with anti-Cdc25A (M-191, Santa Cruz), anti-phospho Ser10 histone H3,
phase (I) and early prophase (P) cells are shown. >200 cells in three independent
d in Supplementary data. (C) Left panel: U2OS cells were synchronized by a double
or without 10 lg/ml cycloheximide. Lysates were analyzed in WB with antibodies
wn. Right panel: The FACS proﬁles represent the DNA content of cells at different
844 O. Timofeev et al. / FEBS Letters 583 (2009) 841–847the endogenous Cdc25A left the nucleus and became distributed
between nucleus and cytoplasm (Fig. 2B). The speciﬁcity of the
Cdc25A antibody is shown in Fig. S1. We also measured accumula-
tion rates of Cdc25A and Cdc25B in G2–M-phases by determining
the stability of both proteins in synchronized HeLa and U2OS cells
that were treated with the protein synthesis inhibitor cyclohexi-
mide. Until early G2 phase (10 h after release from a double thymi-
dine block for U2OS), both phosphatases were degradedwith a half-
life time less than 20 min. Remarkably, Cdc25A was signiﬁcantlyFig. 3. Overexpression of Cdc25A or Cdc25B has similar effects on G2–M transition.
thymidine block as described above. Samples from different intervals after release were ly
M and 2N cells in subsequent G1 phases are shown on the graphs. Statistical analyzes (p
above each pair of columns. Right panel: Western blotting of the lysates obtained in (A)
ﬁxed on coverslips with 4% PFA, stained with pSer10-H3 antibody and Hoechst 33258, an
cells were counted. Mean relative numbers of mitotic cells (positive for pSer10-H3) at 11 h
synchronized as in (A) were ﬁxed with 70% methanol and stained with anti-c-tubulin ant
Mean relative numbers of cells with separated centrosomes at 11 h after release are pr
induced cells, error bars show standard deviations in 3 (or 4 in Fig. 4A) independent exstabilized already at 10 h after release with a half-life period over
20 min, while the stability of Cdc25B at this time was markedly
lower (Fig. 2C). It has been reported that Cdc25A is stabilized in
mitosis via Cdk1/Cyclin B mediated phosphorylation of Ser18,
Ser116 and Ser321 [11,15]. Mass spectrometric analysis of immu-
noprecipitated HA-tagged-Cdc25A (from U2OS cells with inducible
expression of HA-Cdc25A) collected at 10 h (G2 phase) and 14 h
(mitosis) after release detected phosphorylation of Ser18 and
Ser321 in both samples (Fig. S2). Taken together, our results(A) U2OS cell lines inducibly expressing Cdc25A were synchronized by a double
sed forWB or ﬁxed for FACS-Scan analysis. Mean relative numbers of 4N cells in G2–
aired t-test) were performed using GraphPad Prism software, P-values are denoted
with indicated antibodies. (B) Synchronized U2OS Cdc25A or Cdc25B cells (A) were
d analyzed using ﬂuorescence microscopy. In three independent experiments >300
and 12 h after release are presented in the graphs (C) U2OS Cdc25A or Cdc25B cells,
ibodies. Centrosomes were counted for >300 cells in three independent experiments.
esented in the graphs. Bars, 20 lm. White columns – non-induced, grey columns –
periments.
Fig. 4. Cdc25A regulates the activity of Cdk1–2/Cyclin A and Cdk1/Cyclin B in G2. (A) Cdk1 and Cyclin B were immunoprecipitated from lysates of synchronized non-induced
and induced U2OS Cdc25A (left panel) or U2OS Cdc25B cells (right panel) and harvested at 10 h after release from a double thymidine block. Samples were split for histone H1
kinase assays and WB; N = 3. (B) Cdk2 and Cyclin A were immunoprecipitated with corresponding antibodies from 9 h lysates prepared as in (A), and kinase activities were
measured; N = 3. Numbers under autoradiographs indicate the relative densities of bands. (C) Lysates, prepared from synchronized non-induced and induced U2OS Cdc25A
cells, collected at 10 h after release, were depleted of Cdk2 or mock-depleted (non-depleted for Cdk2, normal-rabbit IgGs were used) and subjected to IP with an anti-Cyclin A
antibody. Kinase assays were performed as in (A, B). WB represents a control for immunodepletion efﬁciency; N = 2. (D) Upper panel: HeLa cells transfected with a vector
expressing GFP and Cdc25A-shRNA or control shRNAs were synchronized by a double thymidine block. After release cells were collected at indicated time-points and
analyzed by FACS. Using a bivariate FACS analysis the cell cycle was monitored in transfected cells, expressing GFP. Similar experiments were done with shRNA targeting
Cdc25B (lower panel). To assess for Cdc25A or B repression lysates were probed with indicated antibodies in WB, N = 4. (E) The same lysates as in D, were used for IP with
anti-Cyclin A or anti-Cyclin B antibodies and kinase activities of immunoprecipitated complexes were assayed as in (A).
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prior to activation of major pools of Cdc25B and Cdk1/Cyclin B.To explore the function of Cdc25A at entry into mitosis in more
detail we analyzed the effect of its overexpression in comparison to
846 O. Timofeev et al. / FEBS Letters 583 (2009) 841–847Cdc25B. In cell lines with inducible expression of either Cdc25A or
Cdc25B a series of cell cycle proﬁle analyzes with cells, synchro-
nized at G1–S was performed. FACS analysis of the DNA content
showed only little effect on the accumulation of cells in G2–M,
but a signiﬁcantly earlier appearance of cells in the next G1 phase
upon induction of either Cdc25A or Cdc25B in U2OS (Fig. 3A) or
HeLa cells (not shown). Since FACS analysis cannot indicate the
beginning of mitosis, we analyzed the appearance of the mitotic
marker pH3 Ser10. Induction of Cdc25A and Cdc25B caused an ear-
lier mitotic onset in U2OS cells, which has been detected by FACS
analysis (not shown) or immunoﬂuorescence microscopy
(Fig. 3B) Experiments with HeLa cells inducibly expressing Cdc25A
or B gave similar results (not shown). In agreement with known
data [2,3] we found that overexpression of Cdc25B caused an ear-
lier centrosome splitting in late G2. Interestingly, upon induction
of Cdc25A we observed a similar effect (Fig. 3C). If Cdc25A is
mainly involved in chromatin condensation and acts after Cdc25B
in G2–M, an increase in the number of abnormal cells with con-
densed DNA and unseparated centrosomes should be observed
upon Cdc25A expression. Recently, it was shown that Cdc25A is a
centrosomal protein [16]. Therefore, it is likely that Cdc25A over-
expression initiates centrosome separation by activation of centro-
somal Cdk1/Cyclin B pools.
It is known that Cdc25A can dephosphorylate and activate Cdk2
and Cdk1 in complexes with cyclins both in vitro and in vivo.
Cdc25B dephosphorylates Cdk1 in G2–M, but little is known about
its ability to activate Cdk2 in vivo. To investigate whether Cdc25A
and Cdc25B have different substrate preferences in vitro we per-
formed Cdc25 phosphatase assays using tyrosine-phosphorylated
Cdk1/Cyclin B or Cdk2/Cyclin A as substrates [17]. While Cdc25A
can dephosphorylate both Cdk1/Cyclin B and Cdk2/Cyclin A com-
plexes, Cdc25B was able to activate only Cdk1/Cyclin B (Fig. S3).
To ﬁnd out if these complexes are dephosphorylated by Cdc25A
or B in G2–M, we ﬁrst analyzed the effect of overexpression of
either Cdc25A or Cdc25B on Cdk1 activity in G2. Cdk1 kinase was
immunoprecipitated from U2OS cells which inducibly express
Cdc25A or Cdc25B phosphatases. As expected, at late G2/early M-
phase, Cdk1 kinase activity in Cdc25A and Cdc25B overexpressing
cells was signiﬁcantly elevated (Fig. 4A). Similar results were
obtained when anti-Cyclin B antibodies were used (Fig. 4A). In
agreement with the results obtained in vitro, both Cdk2- and
Cyclin A-associated kinase activities were elevated upon overex-
pression of Cdc25A, whereas Cdc25B overexpression had no effect
on activation of Cyclin A-dependent kinases (Fig. 4B). Although it is
known that only a fraction of Cyclin A is bound to Cdk1 in G2–M,
while its major pool is found in complex with Cdk2, there is evi-
dence that both Cdk1/Cyclin A and Cdk2/Cyclin A complexes play
a role at the G2–M transition [18]. We therefore measured Cyclin
A-associated kinase activity in G2 lysates from Cdc25A inducible
cells after Cdk2 immunodepletion. We detected an increase in Cy-
clin A-associated kinase activity in Cdc25A overexpressing cells
which was reduced in comparison to control-depleted cells
(Fig. 4C) and therefore concluded that Cdc25A can activate both
Cdk1/Cyclin A and Cdk2/Cyclin A complexes in G2–M.
Next we examined activation of Cdk/Cyclin complexes at G2–M
in HeLa cells, transfected with shRNA targeting either Cdc25A or
Cdc25B (Fig. 4D). We immunoprecipitated Cyclin A- or B-associ-
ated kinase complexes and measured their kinase activities.
Remarkably, in Cdc25A repressed cells both Cyclin A- and Cyclin
B-associated activities were strikingly affected. On the contrary,
although repression of Cdc25B caused a drop in Cyclin B/Cdk1
activity, it did not reduce Cyclin A-associated kinase activity signif-
icantly (Fig. 4E). Thus, our data conﬁrm that Cdc25A is able to acti-
vate both Cdk1 and Cdk2 in G2 and at the onset of mitosis, whereas
Cdc25B at this time is active mainly towards Cdk1/Cyclin B
complexes.These studies reveal that during an unperturbed cell cycle
Cdc25A may activate Cyclin A-dependent kinases in G2–M and
thus driving transition from G2 to early prophase, whereas
Cdc25B joins later in prometaphase. Although early accumulation
and degradation of Cdc25B has been reported [19] recently pub-
lished data [20] and our own results demonstrate that accumula-
tion and activation of the main pool of endogenous Cdc25B (not
bound to centrosomes) take place only in late prophase concom-
itantly to Cyclin A degradation [21]. In addition, Cdk1/Cyclin A
mediated phosphorylation of Cdc25B leads to its proteasomal
degradation [22], suggesting that high levels of Cdk1/Cyclin A ki-
nase activity in late G2 may restrain Cdc25B until later stages of
mitosis. Although ectopic expression of Cdc25B in the presence
of DNA damages leads to activation of Cdk2/Cyclin A complexes
[23] little is known about the signiﬁcance of Cdc25B for Cdk2
activation in vivo in non-stressing conditions. On the contrary,
both Cdk2 and Cdk1 are conﬁrmed substrates of Cdc25A
in vivo and overexpression or repression of Cdc25A had pro-
nounced effects on Cyclin A-associated kinase activity. Cyclin A
is known as a key player moving the cell cycle forward from
G2 to mitosis and acting upstream of Cyclin B [24]. Interestingly,
our unpublished observations reveal that in contrast to Cdc25B
protein levels, those of Cdc25A were not reduced upon siRNA
mediated repression of Cyclin A.
We have shown that Cdc25A is activated earlier than Cdc25B at
G2–M. Since it can positively regulate Cdk1/Cyclin B complexes,
we would suggest that it provides a threshold level of Cdk1/Cyclin
B activity, which converts the system to an ultrasensitive state
upon mitotic onset. It is known that activation of Cdk1/Cyclin B
ﬁrst starts on centrosomes and in the cytoplasm, therefore Cdc25B
may trigger initial activation of the cytosolic Cdk1/Cyclin B pool
[4,25]. Our model does not contradict these data, but explains a
discrepancy between the low level of Cdc25B and a high level of
Cdk1/Cyclin B activity in early mitosis. It appears to be likely that
due to its high level in the cytoplasm in late G2, Cdc25A triggers
the initial activation of Cdk1/Cyclin B thus increasing its kinase
activity until prometaphase, when Cdc25B and Cdc25C become
highly active. Alternatively, the impact of Cdc25A on Cdk1/Cyclin
B activity may be indirect, mediated by Cyclin A-dependent
kinases.
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